for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Kalbe Farma Tbk PT

KLBF.JK

Latest Trade

1,665.00IDR

Change

-15.00(-0.89%)

Volume

50,429,400

Today's Range

1,640.00

 - 

1,675.00

52 Week Range

1,240.00

 - 

1,690.00

As of on the Indonesia Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
1,680.00
Open
1,670.00
Volume
50,429,400
3M AVG Volume
601.01
Today's High
1,675.00
Today's Low
1,640.00
52 Week High
1,690.00
52 Week Low
1,240.00
Shares Out (MIL)
46,875.12
Market Cap (MIL)
78,047,080.00
Forward P/E
30.03
Dividend (Yield %)
1.56

Latest Developments

更多

PT Kalbe Farma Tbk announces FY 2014 cash dividend

Government asks PT Kalbe Farma Tbk to recall 26 drugs-Bisnis Indonesia

PT Kalbe Farma Tbk gives FY 2015 revenue guidance below analysts' estimates-The Jakarta Post

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Kalbe Farma Tbk PT

PT Kalbe Farma Tbk is an Indonesia-based company primarily engaged in manufacturing health and nutritional as well as pharmaceutical products. Its business is classified into four segments: prescription drugs, health products, nutritional products as well as distribution and logistics. Its prescription drugs segment manufactures unbranded generic, branded generic and patented drugs. Its health products segment offers over-the-counter (OTC) therapeutic drugs, consumer health products as well as energy and health drinks; some major brands under the segment are Woods, Procold, Extra Joss and Hydro Coco. Its nutritional products segment manufactures a range of products for infants, toddlers, children, teenagers, adults, expectant and lactating mothers as well as elderly; some of major brands under the segment are Prenagen, Milna, Diabetasol and Entrasol. The distribution and logistics segment is operated through its subsidiary, PT Enseval Putera Megatrading Tbk.

Industry

Biotechnology & Drugs

Contact Info

Gedung KALBE Let.Jend Suprato Kav. 4

+62.4.2873888

https://www.kalbe.co.id

Executive Leadership

Bernadette Ruth Irawati Setiady

President Commissioner

.. Vidjongtius

President Director, IR Contact Officer

Sie Djohan

Director

Bujung Nugroho

Director

Ongkie Tedjasurja

Director

Key Stats

2.50 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, IDR)

2016

19.4K

2017

20.2K

2018

21.1K

2019(E)

22.7K
EPS (IDR)

2016

49.060

2017

51.280

2018

52.420

2019(E)

55.952
Price To Earnings (TTM)
31.23
Price To Sales (TTM)
3.57
Price To Book (MRQ)
5.32
Price To Cash Flow (TTM)
25.74
Total Debt To Equity (MRQ)
5.08
LT Debt To Equity (MRQ)
3.69
Return on Investment (TTM)
17.29
Return on Equity (TTM)
13.85

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up